Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Next Steps
View:
Post by Righttothetop on Oct 15, 2020 9:26am

Next Steps

Given that LABS has so far exceeded in executing on their plans for the future and that they actually pulled off a large pharma partnership (as I really did hope they would), here is what I see for the near future:

1) Secure a Stada-like deal for NA.  With obvious access to Bains, that might be easier now than one would think but a NA deal (primarily for the US) with a Tier 1 or 2 pharma would be wonderful

2) Get into the beverage market with a partnership with RedBull or Monster.  You have to believe that those 'X-Games' type companies are licking their chops to find a way to engage their market with a CBD/THC based offering and LABS, with the credibilty it now has globally and their GMP manufacturing platform, offers an excellent partner with plenty of scale and regionalized production.  Realize that this is a bit of a stretch and outside of the pharma business model, but this would be massive.  May as well scoop the others before they get there....cause they will, especially if the US opens up.

3) Keep working with research entities and get the brand out there.

4) Get the damn SP up so we can list in the US.  We have all this high horsepower on the Board, we need to use them!  And when I mean get the SP up, I don't mean a reverse split.

In the end, LABS is doing exactly what they said they would, and have been executing flawlessly.  They need to secure EU GMP quickly, to maintain the positive street cred and start moving to operational excellence to give the markets some peace.

While the price is bouncing around for a while, and while COVID didn't do us any favours, this company is an investment that will pay off large, sooner than one thinks.

IMO
Comment by allibabba on Oct 15, 2020 9:47am
I agree with everything you mention aside from the US.  If the US legalizes every canadian company will disappear.  Do you really think they will canadian companies take profits from US companies.  Not a hope in hell.
Comment by Righttothetop on Oct 15, 2020 9:52am
If the Canadian company is listed in the US and has ties to the US, the US would allow it...hence the reason to get into bed with a US based pharma, list on a US exchange.
Comment by allibabba on Oct 15, 2020 9:58am
That's a great point but keep in mind there are companies in the US already doing what LABS does.  The cannabis medical industry was alive and well long before LABS existed.  I am invested here and hope for the best but I do like to look at both sides of the coin.  I am also a bit bitter at the recent plunge but I should have known better.
Comment by Righttothetop on Oct 15, 2020 11:00am
I hear you brother.  Bitter, disappointed, dismayed, whatever you want to call it.  But I take solace in the fact that LABS has done exactly what they set out to do, COVID fiasco nothwithstanding and even despite COVID, they have an allstart team on the BoD and have just been given a massive credibility boost by a $2bil pharma that has a multi-gazillion dollar hedge fund as an owner ...more  
Comment by Lemoyne on Oct 15, 2020 1:30pm
LABS has an edge intly. It has experience navigating different jurisdictions and has a good network foundation. It's intl oil and derivatives GMP licences are rare in the industry, considering most intl GMP licences in the industry are for flower. Additionnaly, those licences take resources and time to obtain. Also, as mentioned, it now has strong track record for production, reputation for ...more  
Comment by allibabba on Oct 15, 2020 4:44pm
All good points but what I'd like to know is who has been supplying the cannabis medical companies before Medipharm came along.  Oils and capsules have been available since at least 2009 so someone already has this in place.  I don't know who it is but I'm willing to bet there are already large pharmaceutical companies doing exactly this.  
Comment by Lemoyne on Oct 15, 2020 5:43pm
Good question. From what I understand, big pharma in the USA hasn't jumped over the fence yet because cannabis is strictly regulated (schedule 1). They are building their patent portfolios and lie in wait for federal descheduling. Once that happens, it's probably gonna be a race to get product across the US and interesting markets intly. And that's where businesses, from countries ...more  
Comment by lscfa on Oct 16, 2020 1:16am
LP's like Tilray have had their own extraction ops for years. Some newcomers outsource extraction. MediPharm and Valens are going beyond extraction and becoming contract manufacturers.   
Comment by Lemoyne on Oct 16, 2020 9:18am
https://equity.guru/2020/10/15/medipharm-labs-labs-t-hitches-their-white-label-distribution-wagon-to-european-pharma-giant-stada-arzneimittel-ag-stadf-q/
Comment by BushweedJA on Oct 18, 2020 9:24pm
This post has been removed in accordance with Community Policy
Comment by JFKFKJGKF on Oct 18, 2020 10:32pm
This post has been removed in accordance with Community Policy
Comment by allibabba on Oct 15, 2020 4:46pm
If someone can prove to me that there are not large companies who already have a foothold on this i will certainly buy more shares.  For now I am hopeful but skeptical.
Comment by Lemoyne on Oct 15, 2020 8:11pm
Although not US based, Teva is in it for sure, big pharma.
Comment by BushweedJA on Oct 16, 2020 1:05am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse